References in periodicals archive

* Aminosalicylates: Sulfasalazine (Azulfidine), olsalazine (Dipentum), mesalamine (Apriso, Asacol), balsalazide (Colazol)

Controlling Symptoms of Inflammatory Bowel Disease: Many of the medications used to treat IBD target the chronic inflammation that disrupts digestive function

Archavlis et al., "A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis," The American Journal of Gastroenterology, vol.

Comparison of Concomitant Mesalamine and Immunomodulator Therapy and Immunomodulator Monotherapy for Crohn's Disease

* Aminosalicylates, such as mesalamine (Lialda), mesalamine extended-release (Apriso), olsalazine (Dipentum), and balsalazide (Colazal)

Ulcerative colitis: avoid certain foods during flare-ups: red meat, alcohol, and milk and milk-based products may aggravate UC symptoms

Common aminosalicylates used in IBD include sulfasalazine, balsalazide, mesalamine, and olsalazine. Sulfasalazine is a pro-drug of 5-ASA linked to sulfapyridine, which allows passage to the colon.

Remission before pregnancy the goal for IBD patients

Children were defined as having IBD if they had either three or more health care visits for Crohn's disease or ulcerative colitis during the study's time frame, or "at least one health care contact for Crohn's disease or ulcerative colitis and at least one pharmacy claim for any of the following medications: mesalamine, olsalazine, balsalazide, sulfasalazine, 6-mercaptopurine, azathioprine, methotrexate, enteral budesonide, or biologies (infliximab, adalimumab, certolizumab, or natalizumab)."

Chronic narcotic use high in children with IBD

The most frequently prescribed aminosalicylates used to treat IBD are mesalazine, sulfasalazine, olsalazine, and balsalazide.

Classical and recent advances in the treatment of inflammatory bowel diseases

Nephrotoxicity associated with olsalazine. Am J Med.

Granulomatous Interstitial Nephritis as a Manifestation of Crohn Disease

This group includes mesalamine, or 5-aminosalicylic acid (5-ASA), sulphasalazine, olsalazine, and balsalazide.

Medication profiles of patients in the University of Puerto Rico inflammatory bowel disease registry